References
- Ventriglia J, Paciolla I, Pisano C, Cecere SC, Di Napoli M, Tambaro R, Califano D, Losito S, Scognamiglio G, Setola SV, et al. Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives. Cancer Treat Rev. 2017;59:109–16. doi:https://doi.org/10.1016/j.ctrv.2017.07.008
- Riaz Rajoka MS, Shi J, Zhu J, Shao D, Huang Q, Yang H, Jin M. Capacity of lactic acid bacteria in immunity enhancement and cancer prevention. Appl Microbiol Biotechnol. 2017;101(1):35–45. doi:https://doi.org/10.1007/s00253-016-8005-7
- Msrra B, Fanga H, Padhiard AA, Zeng X, Khurshide M, Hec Z, Zhaoa L. Characterization and anti-tumor activity of exopolysaccharide produced by Lactobacillus kefiri isolated from Chinese kefir grains. J Funct Foods 2019;63:103588.
- Riaz Rajoka MS, Zhao H, Mehwish HM, Li N, Lu Y, Lian Z, Shao D, Jin M, Li Q, Zhao L, et al. Anti-tumor potential of cell free culture supernatant of Lactobacillus rhamnosus strains isolated from human breast milk. Food Res Int. 2019;123:286–97. doi:https://doi.org/10.1016/j.foodres.2019.05.002
- Hu Z, Ma D. The precision prevention and therapy of HPV-related cervical cancer: new concepts and clinical implications. Cancer Med. 2018;7(10):5217–36. doi:https://doi.org/10.1002/cam4.1501
- Tewari KS, Sill MW, Long HJ, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–43. doi:https://doi.org/10.1056/NEJMoa1309748
- Kolusheva S, Wachtel E, Jelinek R. Biomimetic lipid/polymer colorimetric membranes: molecular and cooperative properties. J Lipid Res. 2003;44(1):65–71. doi:https://doi.org/10.1194/jlr.m200136-jlr200
- Maier T, Jenni S, Ban N. Architecture of mammalian fatty acid synthase at 4.5 A resolution. Science. 2006;311(5765):1258–62. doi:https://doi.org/10.1126/science.1123248
- Zaytseva YY, Rychahou PG, Gulhati P, Elliott VA, Mustain WC, O’Connor K, Morris AJ, Sunkara M, Weiss HL, Lee EY, et al. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res. 2012;72(6):1504–17. doi:https://doi.org/10.1158/0008-5472.CAN-11-4057
- Uddin S, Hussain AR, Ahmed M, Abubaker J, Al-Sanea N, AbdulJabbar A, Ashari LH, Alhomoud S, Al-Dayel F, Bavi P, et al. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target. Am J Gastroenterol. 2009;104(7):1790–801. doi:https://doi.org/10.1038/ajg.2009.230
- Jiang L, Wang H, Li J, Fang X, Pan H, Yuan X, Zhang P. Up-regulated FASN expression promotes transcoelomic metastasis of ovarian cancer cell through epithelial-mesenchymal transition. Int J Mol Sci. 2014;15(7):11539–54. doi:https://doi.org/10.3390/ijms150711539
- Lei T, Zhu Y, Jiang C, Wang Y, Fu J, Fan Z, Qin H. MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase. Mol Med Rep. 2016;14(2):1255–62. doi:https://doi.org/10.3892/mmr.2016.5370
- Tao T, Su Q, Xu S, Deng J, Zhou S, Zhuang Y, Huang Y, He C, He S, Peng M, et al. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis. J Cell Physiol. 2019;234(3):3088–104. doi:https://doi.org/10.1002/jcp.27129
- Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010;466(7308):835–40. doi:https://doi.org/10.1038/nature09267
- Peng R, Cheng X, Zhang Y, Lu X, Hu Z. miR-214 down-regulates MKK3 and suppresses malignant phenotypes of cervical cancer cells. Gene. 2020;724:144146 doi:https://doi.org/10.1016/j.gene.2019.144146
- Ma J, Zhang F, Sun P. miR-140-3p impedes the proliferation of human cervical cancer cells by targeting RRM2 to induce cell-cycle arrest and early apoptosis. Bioorg Med Chem. 2020;28(3):115283 doi:https://doi.org/10.1016/j.bmc.2019.115283
- Chen M, Liu LX. MiR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C/ZEB1/2 signal axis. Dig Dis Sci. 2020;65(8):2442–51. doi:https://doi.org/10.1007/s10620-019-05916-9
- Chen Y, Kuang D, Zhao X, Chen D, Wang X, Yang Q, Wan J, Zhu Y, Wang Y, Zhang S, et al. miR-497-5p inhibits cell proliferation and invasion by targeting KCa3.1 in angiosarcoma. Oncotarget. 2016;7(36):58148–61. doi:https://doi.org/10.18632/oncotarget.11252
- Feng L, Cheng K, Zang R, Wang Q, Wang J. miR-497-5p inhibits gastric cancer cell proliferation and growth through targeting PDK3. Biosci Rep. 2019;39(9). doi:https://doi.org/10.1042/BSR20190654
- Li G, Wang K, Wang J, Qin S, Sun X, Ren H. miR-497-5p inhibits tumor cell growth and invasion by targeting SOX5 in non-small-cell lung cancer. J Cell Biochem. 2019;120(6):10587–95. doi:https://doi.org/10.1002/jcb.28345
- Therneau TM, Grambsch PM. Modeling survival data: Extending the Cox model. Springer, 2000.
- Luo L, Wang M, Li X, Luo C, Tan S, Yin S, Liu L, Zhu X. A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression. Cancer Cell Int. 2020;20:372. doi:https://doi.org/10.1186/s12935-020-01471-w
- Zhao Y, Zhu C, Chang Q, Peng P, Yang J, Liu C, Liu Y, Chen X, Liu Y, Cheng R, et al. MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7. PloS One. 2020;15(11):e0242179 doi:https://doi.org/10.1371/journal.pone.0242179
- Li N, Bu X, Tian X, Wu P, Yang L, Huang P. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Nutr Cancer. 2012;64(6):864–70. doi:https://doi.org/10.1080/01635581.2012.701704
- Xu LX, Hao LJ, Ma JQ, Liu JK, Hasim A. SIRT3 promotes the invasion and metastasis of cervical cancer cells by regulating fatty acid synthase. Mol Cell Biochem. 2020;464(1-2):11–20. doi:https://doi.org/10.1007/s11010-019-03644-2
- Zhou L, Jiang S, Fu Q, Smith K, Tu K, Li H, Zhao Y. FASN, ErbB2-mediated glycolysis is required for breast cancer cell migration. Oncol Rep. 2016;35(5):2715–22. doi:https://doi.org/10.3892/or.2016.4627
- Jiang Y, Yin X, Wu L, Qin Q, Xu J. MAPK/P53-mediated FASN expression in bone tumors. Oncol Lett. 2017;13(6):4035–8. doi:https://doi.org/10.3892/ol.2017.6015
- Ezzeddini R, Taghikhani M, Somi MH, Samadi N, Rasaee MJ. Clinical importance of FASN in relation to HIF-1α and SREBP-1c in gastric adenocarcinoma. Life Sci. 2019;224:169–76. doi:https://doi.org/10.1016/j.lfs.2019.03.056
- Xu G-S, Li Z-W, Huang Z-P, Brunicardi FC, Jia F, Song C, Zou H-J, Sun R-F. MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1. Mol Genet Genomic Med. 2019;7(10):e00860. doi:https://doi.org/10.1002/mgg3.860
- Gharib E, Nasri Nasrabadi P, Reza Zali M. M. miR-497-5p mediates starvation-induced death in colon cancer cells by targeting acyl-CoA synthetase-5 and modulation of lipid metabolism. J Cell Physiol. 2020;235(7-8):5570–89. doi:https://doi.org/10.1002/jcp.29488